Hematologist, with a focus on hematopoietic cell transplantation and hematopoietic cellular therapies. Therapeutic innovations. Head & qualified person: Centre de Therapie Cellulaire, Institut Paoli-Calmettes Comprehensive Cancer Centre. Professor of Medicine in Cell Biology at Aix-Marseille Université School of Medicine. Coordinating physician of the "Centre d'Investigations Cliniques en Biothérapies" Inserm-AMU-AP-HM-IPC, all in Marseilles, France.

Professor Thomas Cluzeau (MD, PhD) is head of the Hematology Department at the Centre Hospitalier Universitaire de Nice (CHU), France (member of Cote d'Azur University). His research interests include myelodysplastic syndromes and acute leukemia (including myeloid and lymphoid). He performs basic and translational sciences in the Mediterranean Center of Molecular Medicine (INSERM U1065), Nice, France, with international collaborations (including Moffitt Cancer Center and Research Institute, Tampa, FL, USA). He is a member of several French cooperative groups and is active in clinical research in the Groupe Francophone des Myélodysplasies (GFM), the Acute Leukemia French Association (ALFA) and the Group for Research in Adult Lymphoblastic Leukemia (GRAALL).

I am a medical doctor working as a consultant hematologist at the First-in-human/Phase 1 unit, Center for Clinical Cancer Studies, at Karolinska University Hospital, Stockholm, Sweden. I am also currently completing my PhD-work in Professor Eva Hellström Lindberg group at Karolinska Institutet. My main research focus is on the genetic lanscape and prognostic markers of Myelodysplastic Syndromes.